Niagen Bioscience has been announced as the premiere sponsor of the inaugural “NAD for Health: Opportunities & Challenges” conference, hosted by the University of Copenhagen. The event aims to bring together researchers, industry experts, and healthcare professionals to discuss recent developments and future directions in NAD-related health research.
The conference will cover a range of topics including the biological roles of NAD, therapeutic applications, and the challenges faced in translating NAD science into clinical practice. Niagen Bioscience’s sponsorship highlights its commitment to advancing research in this field.
**Why this matters**
NAD (Nicotinamide adenine dinucleotide) plays a crucial role in cellular metabolism and aging. Understanding its functions and potential therapeutic uses could lead to significant advancements in health and disease management. This conference provides a platform for collaboration and knowledge exchange that may accelerate innovation in NAD-based treatments.
Source: NewsData